These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23643757)

  • 1. [100 essential drugs. An internal medicine approach].
    Thomas M; Arlet P; Aumaitre O; Cosserat J; Grosbois B; Guillevin L; Kettaneh A; Le Jeunne C; Massot C; Morlat P
    Rev Med Interne; 2013 Aug; 34(8):460-4. PubMed ID: 23643757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adequancy of the pharmacological disponibility in a Department of Internal Medicine to the WHO essential drug list].
    Díaz Peromingo JA; Villamil Cajoto I; Buján de Gonzalo L
    An Med Interna; 2007 Apr; 24(4):173-6. PubMed ID: 17867900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A proposal for reforming psychologists' training in France and in the European Union].
    Bouchard JP
    Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study.
    Adekoya I; Maraj D; Steiner L; Yaphe H; Moja L; Magrini N; Cooke G; Loeb M; Persaud N
    Lancet Infect Dis; 2021 Oct; 21(10):1429-1440. PubMed ID: 34332706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding medicines for neurologic disorders on the WHO Model List.
    Rimmer K; Shah H; Thakur K
    Neurology; 2017 Mar; 88(10):e87-e91. PubMed ID: 28265046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ensuring palliative medicine availability: the development of the IAHPC list of essential medicines for palliative care.
    De Lima L; Krakauer EL; Lorenz K; Praill D; Macdonald N; Doyle D
    J Pain Symptom Manage; 2007 May; 33(5):521-6. PubMed ID: 17482041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative comparison between the essential medicines for rheumatic diseases in children and young people in Africa and the WHO model list.
    Slamang W; Scott C; Foster HE
    Pediatr Rheumatol Online J; 2024 Jul; 22(1):63. PubMed ID: 38965620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa.
    Rowlands A; Ameyaw E; Rutagarama F; Dipesalema J; Majaliwa ES; Mbogo J; Ogle GD; Chanoine JP
    Horm Res Paediatr; 2018; 90(2):82-92. PubMed ID: 30048982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selection and use of essential medicines.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (985):i-xiv, 1-219, back cover. PubMed ID: 25080778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selection and use of essential medicines.
    World Health Organization
    World Health Organ Tech Rep Ser; 2011; (965):i-xiv, 1-249. PubMed ID: 22891532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential medicines for emergency care in Africa.
    Broccoli MC; Pigoga JL; Nyirenda M; Wallis L; Calvello Hynes EJ
    Emerg Med J; 2018 Jul; 35(7):412-419. PubMed ID: 29627770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The list of drugs in the Popular Pharmacy Program and the Brazilian National Pharmaceutical Care Policy].
    Yamauti SM; Barberato-Filho S; Lopes LC
    Cad Saude Publica; 2015 Aug; 31(8):1648-62. PubMed ID: 26375644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selection and use of essential medicines. Report of the WHO expert committee, 2005 (including the 14th model list of essential medicines).
    World Health Organ Tech Rep Ser; 2006; (933):1-119, back cover. PubMed ID: 17566509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selection and use of essential medicines.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2008; (950):backcover, vii-174. PubMed ID: 18754303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of essential medicines for cardiovascular diseases in countries of the WHO Eastern Mediterranean Region.
    Mehrtash H; Laing R; Wirtz VJ
    East Mediterr Health J; 2018 Jul; 24(5):427-434. PubMed ID: 30043961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.
    Kishore SP; Blank E; Heller DJ; Patel A; Peters A; Price M; Vidula M; Fuster V; Onuma O; Huffman MD; Vedanthan R
    J Am Coll Cardiol; 2018 Feb; 71(5):564-574. PubMed ID: 29406862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Selection and Use of Essential Medicines.
    World Health Organ Tech Rep Ser; 2015; (994):vii-xv, 1-546. PubMed ID: 27183787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selection and use of essential medicines.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2009; (958):1-242, back cover. PubMed ID: 20560299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding a medicine to the WHO model list of essential medicines.
    Kishore SP; Herbstman BJ
    Clin Pharmacol Ther; 2009 Mar; 85(3):237-9. PubMed ID: 19223877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selection and use of essential medicines. Report of the WHO Expert Committee, 2002 (including the 12th Model list of essential medicines).
    World Health Organ Tech Rep Ser; 2003; 914():i-vi, 1-126. PubMed ID: 12872478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.